My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 270

    1.

    In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.

    Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV, DiLorenzo TP.

    Diabetes. 2007 Oct;56(10):2551-60. Epub 2007 Jul 9.PMID: 17620420 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.

    Enée E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P.

    J Immunol. 2008 Apr 15;180(8):5430-8.PMID: 18390725 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.

    Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M, DiLorenzo TP, Serreze DV.

    J Immunol. 2006 Mar 1;176(5):3257-65.PMID: 16493087 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.

    Wong FS, Siew LK, Scott G, Thomas IJ, Chapman S, Viret C, Wen L.

    Diabetes. 2009 May;58(5):1156-64. Epub 2009 Feb 10.PMID: 19208910 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.

    Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R.

    Diabetes. 2008 May;57(5):1312-20. Epub 2008 Feb 27.PMID: 18305140 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.

    Chaparro RJ, Burton AR, Serreze DV, Vignali DA, DiLorenzo TP.

    J Immunol Methods. 2008 Jun 1;335(1-2):106-15. Epub 2008 Apr 8.PMID: 18439618 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities.

    DiLorenzo TP, Lieberman SM, Takaki T, Honda S, Chapman HD, Santamaria P, Serreze DV, Nathenson SG.

    Clin Immunol. 2002 Dec;105(3):332-41.PMID: 12498815 [PubMed - indexed for MEDLINE]Related articles

    8.

    Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.

    Wong CP, Li L, Frelinger JA, Tisch R.

    J Immunol. 2006 Feb 1;176(3):1637-44.PMID: 16424193 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.

    Lieberman SM, Takaki T, Han B, Santamaria P, Serreze DV, DiLorenzo TP.

    J Immunol. 2004 Dec 1;173(11):6727-34.PMID: 15557165 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.

    Toma A, Laïka T, Haddouk S, Luce S, Briand JP, Camoin L, Connan F, Lambert M, Caillat-Zucman S, Carel JC, Muller S, Choppin J, Lemonnier F, Boitard C.

    Diabetes. 2009 Feb;58(2):394-402. Epub 2008 Nov 14.PMID: 19011169 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.

    Takaki T, Lieberman SM, Holl TM, Han B, Santamaria P, Serreze DV, DiLorenzo TP.

    J Immunol. 2004 Aug 15;173(4):2530-41.PMID: 15294969 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.

    Bercovici N, Heurtier A, Vizler C, Pardigon N, Cambouris C, Desreumaux P, Liblau R.

    J Immunol. 2000 Jul 1;165(1):202-10.PMID: 10861053 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

    Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P.

    J Clin Invest. 1999 Apr;103(8):1201-9.PMID: 10207172 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.

    Lieberman SM, Evans AM, Han B, Takaki T, Vinnitskaya Y, Caldwell JA, Serreze DV, Shabanowitz J, Hunt DF, Nathenson SG, Santamaria P, DiLorenzo TP.

    Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8384-8. Epub 2003 Jun 18.PMID: 12815107 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.

    Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P.

    J Immunol. 2003 Dec 15;171(12):6900-9.PMID: 14662897 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.

    Anderson B, Park BJ, Verdaguer J, Amrani A, Santamaria P.

    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9311-6.PMID: 10430939 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice.

    Hayward SL, Bautista-Lopez N, Suzuki K, Atrazhev A, Dickie P, Elliott JF.

    J Immunol. 2006 Jun 15;176(12):7715-25.PMID: 16751419 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Targeting of pancreatic glia in type 1 diabetes.

    Tsui H, Chan Y, Tang L, Winer S, Cheung RK, Paltser G, Selvanantham T, Elford AR, Ellis JR, Becker DJ, Ohashi PS, Dosch HM.

    Diabetes. 2008 Apr;57(4):918-28. Epub 2008 Jan 15.PMID: 18198358 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.

    Ejrnaes M, Videbaek N, Christen U, Cooke A, Michelsen BK, von Herrath M.

    J Immunol. 2005 Mar 1;174(5):2746-55.PMID: 15728483 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.

    Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, Appel MC.

    Clin Immunol. 2004 Sep;112(3):273-83.PMID: 15308121 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity